View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Cetuximab 250 / Paclitaxel 40 / Carboplatin 2 / Radiation, Head and Neck Tumors, Cycle 2+
Protocol-ID: 621 V1.1 (Mini), CETU250/PACL40/CRBP2/Radiation, Head and Neck Tumors, C2+Indication(s)
- Head and Neck Tumors (Squamous Cell); ICD-10 C76.0
- Nasopharyngeal Carcinoma; ICD-10 C11.8, C11.9, C11.-
ST Radiotherapy: simultaneous Radiation |
| 5 irradiations per week a 1.8 Gy, up to a total dose of 70.2 Gy. |
Links
- One-hour paclitaxel infusions: review of safety and efficacy. [PMID]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 25.02.2020